Company Data

HilleVax Inc.

Ticker
HLVX
Current Price
$1.85 -0.54%
Market Cap
$92.8M
Price Target
Refer to Report
Volume
8.6K
52wk Range
$1.34 - $15.6
Advanced Market Data

Overview

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm’s initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy